Skip to content

Alto Neuroscience ANRO Common Stock Shares Issued

Common Stock Shares Issued at other companies

Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
58M+3.7%
IAR
Integra LifeSciencesIART
92.2M0.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
72.3M+1.0%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
Medtronic logo
MedtronicMDT
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's common stock shares issued?
Alto Neuroscience (ANRO) reported common stock shares issued of 35.1M in Q1 2026.
How has Alto Neuroscience's common stock shares issued changed year-over-year?
Alto Neuroscience's common stock shares issued increased by 29.5% year-over-year, from 27.1M to 35.1M.
What is the long-term trend for Alto Neuroscience's common stock shares issued?
Over 2 years (2023 to 2025), Alto Neuroscience's common stock shares issued has grown at a 188.6% compound annual growth rate (CAGR), from 3.8M to 31.9M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.